(Q42690644)

4 November 2017

title

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study (English)

1 reference

4 November 2017

1 reference

2

Julio Bobes

1 reference

4 November 2017

Enrique Alvarez

1

1 reference

4 November 2017

Juan-Carlos Gómez

3

1 reference

4 November 2017

José Antonio Sacristán

4

1 reference

4 November 2017

Fernando Cañas

5

1 reference

4 November 2017

José Luis Carrasco

6

1 reference

4 November 2017

Josep Gascón

7

1 reference

4 November 2017

Juan Gibert

8

1 reference

4 November 2017

Miguel Gutiérrez

9

1 reference

4 November 2017

EUROPA Study Group

10

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Neuropsychopharmacology

4 November 2017

published in

1 reference

4 November 2017

volume

13

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

39-48

1 reference

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

Defining treatment refractoriness in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

1 reference

7 January 2021

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900079-2

7 January 2021

10.1016/S0924-977X(02)00079-2

Identifiers

DOI

1 reference

release_xqskltpbfve3pperhca7qbwz3a

4 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xqskltpbfve3pperhca7qbwz3a

24 November 2022

mapped directly with Wikidata item

1 reference